Ludvigsson J, Samuelsson U, Beauforts C, Deschamps I, Dorchy H, Drash A, Francois R, Herz G, New M, Schober E
Diabetologia. 1986 Apr;29(4):207-10. doi: 10.1007/BF00454876.
The presence of HLA-DR 3 was analysed in 745 patients with Type 1 (insulin-dependent) diabetes with age at diagnosis between 1-19 years. HLA-DR 3 and/or 4 was found in 678/745 (91%) of the patients. Presence of DR2 with neither DR 3 nor 4 was demonstrated in 15 patients. Patients with HLA-DR 3 without DR 4 presented with Type 1 diabetes more evenly over the year; they also presented without incidence peaks at 7 years or 10-11 years, as seen especially in DR 3/4 patients. The DR 3 patients more often had mild disease with less ketonuria at diagnosis, less often ketoacidotic symptoms and more often a subsequent partial remission. The apparently more severe disease among diabetic girls may, at least to some extent, be explained by their higher prevalence of HLA-DR 4. The differences found were similar in North America and Europe. The results suggest that Type 1 diabetes is a genetically heterogeneous disease and that HLA-typing may be a useful marker of this heterogeneity.
对745例1型(胰岛素依赖型)糖尿病患者进行了HLA - DR 3检测,这些患者诊断时年龄在1至19岁之间。在745例患者中有678例(91%)发现了HLA - DR 3和/或4。15例患者显示存在DR2,但不存在DR 3和DR 4。没有DR 4的HLA - DR 3患者在一年中患1型糖尿病的情况更为均匀;他们也没有出现7岁或10至11岁时的发病高峰,而这在DR 3/4患者中尤为明显。DR 3患者在诊断时病情往往较轻,酮尿较少,酮症酸中毒症状较少,随后部分缓解的情况较多。糖尿病女孩中明显更严重的病情至少在一定程度上可能是由于她们中HLA - DR 4的患病率较高。在北美和欧洲发现的差异相似。结果表明,1型糖尿病是一种基因异质性疾病,HLA分型可能是这种异质性的有用标志物。